« Back to Record
Citation APA

Rugo, H. H., Cortes, J., Awada, A., O'Shaughnessy, J., Twelves, C., Im, S. –., Hannah, A. L., Lu, L., Sy, S., Caygill, K., Zajchowski, D. D., Davis, D. D., Tagliaferri, M., Hoch, U., & Perez, E. A. (2018). Change in Topoisomerase 1-Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol. Clinical cancer research, 24(14), 3348-3357. doi:10.1158/1078-0432.CCR-17-3059


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/279763

Rugo, H. H., Cortes, J., Awada, A., O'Shaughnessy, J., Twelves, C., Im, S. –., Hannah, A. L., Lu, L., Sy, S., Caygill, K., Zajchowski, D. D., Davis, D. D., Tagliaferri, M., Hoch, U., & Perez, E. A. (2018). Change in Topoisomerase 1-Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol. Clinical cancer research, 24(14), 3348-3357. doi:10.1158/1078-0432.CCR-17-3059